CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

被引：0
|
作者：
Jing, P. [1 ,2 ]
Niu, Q. [2 ]
Deng, B. [3 ]
Liu, S. [1 ]
Wu, T. [4 ]
Gao, Z. [4 ]
Chang, A. H. [5 ]
Feng, X. [2 ]
Tong, C. [1 ]
机构：
[1] Beijing Boren Hosp, Dept Hematol, Beijing, Peoples R China
[2] Inst Hematol & Hosp Blood Dis, Tianjin, Peoples R China
[3] Beijing Boren Hosp, Cytol Lab, Beijing, Peoples R China
[4] Beijing Boren Hosp, Dept Bone Marrow Transplantat, Beijing, Peoples R China
[5] Tongji Univ, Sch Med, Clin Translat Res Ctr, Shanghai, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P2287
引用
收藏
页码：1723 / 1723
页数：1
相关论文
共 50 条
  • [1] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Jing Pan
    Qing Niu
    Biping Deng
    Shuangyou Liu
    Tong Wu
    Zhiyong Gao
    Zhaoli Liu
    Yue Zhang
    Xiaomin Qu
    Yanlei Zhang
    Shaohui Liu
    Zhuojun Ling
    Yuehui Lin
    Yongqiang Zhao
    Yanzhi Song
    Xiyou Tan
    Yan Zhang
    Zhihui Li
    Zhichao Yin
    Bingzhen Chen
    Xinjian Yu
    Ju Yan
    Qinlong Zheng
    Xuan Zhou
    Jin Gao
    Alex H. Chang
    Xiaoming Feng
    Chunrong Tong
    Leukemia, 2019, 33 : 2854 - 2866
  • [2] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Pan, Jing
    Niu, Qing
    Deng, Biping
    Liu, Shuangyou
    Wu, Tong
    Gao, Zhiyong
    Liu, Zhaoli
    Zhang, Yue
    Qu, Xiaomin
    Zhang, Yanlei
    Liu, Shaohui
    Ling, Zhuojun
    Lin, Yuehui
    Zhao, Yongqiang
    Song, Yanzhi
    Tan, Xiyou
    Zhang, Yan
    Li, Zhihui
    Yin, Zhichao
    Chen, Bingzhen
    Yu, Xinjian
    Yan, Ju
    Zheng, Qinlong
    Zhou, Xuan
    Gao, Jin
    Chang, Alex H.
    Feng, Xiaoming
    Tong, Chunrong
    LEUKEMIA, 2019, 33 (12) : 2854 - 2866
  • [3] Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    BLOOD, 2024, 144 : 2819 - 2819
  • [4] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [5] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
    Phely, Laurent
    Hensen, Luca
    Faul, Christoph
    Ruff, Christer Alexander
    Schneider, Dina
    Bethge, Wolfgang Andreas
    Lengerke, Claudia
    JAMA ONCOLOGY, 2024, 10 (06) : 821 - 824
  • [6] CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy
    Yu, Xinjian
    Li, Pan
    Feng, Heyuan
    Kang, Jian
    Zheng, Xichang
    Zhang, Yunmei
    Yang, Wenhong
    Wu, Tong
    Liu, Shuangyou
    BLOOD, 2020, 136
  • [7] CAR T-Cell Therapy Pediatric patients with relapsed and refractory acute lymphoblastic leukemia
    Callahan, Colleen
    Baniewicz, Diane
    Ely, Beth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : 22 - 28
  • [8] Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
    Hanren Dai
    Zhiqiang Wu
    Hejin Jia
    Chuan Tong
    Yelei Guo
    Dongdong Ti
    Xiao Han
    Yang Liu
    Wenying Zhang
    Chunmeng Wang
    Yajing Zhang
    Meixia Chen
    Qingming Yang
    Yao Wang
    Weidong Han
    Journal of Hematology & Oncology, 13
  • [9] Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Kong, Delin
    Geng, Jia
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [10] CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Retrospective Study
    Zhao, Liping
    Zhou, Qi
    Chen, Chen
    Ling, Zhuojun
    Wang, Kai
    Wu, Fan
    Xu, Jinlong
    Duan, Jiajia
    Wang, Zelin
    Wang, Quangang
    Pan, Jing
    BLOOD, 2023, 142
12345